Generic drug development current scenario

Generic drugs are a key part of today's healthcare systems. They provide cheaper options compared to brand-name drugs, but they are just as safe, effective, and high quality. These drugs work the same way as the original medicines because they contain the same active ingredients. They help lower the cost of healthcare and make medicines more accessible, especially in poorer countries. This paper looks at the worldwide situation of making generic drugs, how patent endings affect the market, and the different ways medicines are sold in various regions. It also covers the rules and regulations in the US, Europe, India, and the WHO's Prequalification Programme. The paper gives a close look at the situation in India, including government efforts like the Jan Aushadhi scheme and changes made to make generic drugs more available and trusted. It also discusses some challenges, like making sure the drugs are of good quality, gaining trust from doctors, and following production rules. The paper ends with a comparison of prices between generic and branded drugs to show how much cheaper generics are

Publication Details

Journal
International Journal of Pharmaceutical Research and Applications
Published
2025-05-01
DOI
https://doi.org/10.35629/4494-100594100
Primary Topic
Geochemistry and Geologic Mapping
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Generic drug development current scenario

International Journal of Pharmaceutical Research and Applications
Geochemistry and Geologic Mapping
article

Generic drug development current scenario

article en

Abstract

Generic drugs are a key part of today's healthcare systems. They provide cheaper options compared to brand-name drugs, but they are just as safe, effective, and high quality. These drugs work the same way as the original medicines because they contain the same active ingredients. They help lower the cost of healthcare and make medicines more accessible, especially in poorer countries. This paper looks at the worldwide situation of making generic drugs, how patent endings affect the market, and the different ways medicines are sold in various regions. It also covers the rules and regulations in the US, Europe, India, and the WHO's Prequalification Programme. The paper gives a close look at the situation in India, including government efforts like the Jan Aushadhi scheme and changes made to make generic drugs more available and trusted. It also discusses some challenges, like making sure the drugs are of good quality, gaining trust from doctors, and following production rules. The paper ends with a comparison of prices between generic and branded drugs to show how much cheaper generics are

International Journal of Pharmaceutical Research and ApplicationsVol. 10(5)
No poverty
Openalex Percentile: Top 38%
Geochemistry and Geologic Mapping
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.